反応式
[CH3:1][O:2][C:3]1[C:4]([O:25][CH3:26])=[CH:5][C:6]2[C:7]3[N:8]([CH2:22][CH2:23][N:24]=3)[C:9](/[CH:13]=[C:14](/[C:16]3[CH:17]=[N:18][CH:19]=[CH:20][CH:21]=3)\[OH:15])=[N:10][C:11]=2[CH:12]=1.[ClH:27]>O1CCOCC1>[ClH:27].[CH3:1][O:2][C:3]1[C:4]([O:25][CH3:26])=[CH:5][C:6]2[C:7]3[N:8]([CH2:22][CH2:23][N:24]=3)[C:9](/[CH:13]=[C:14](/[C:16]3[CH:17]=[N:18][CH:19]=[CH:20][CH:21]=3)\[OH:15])=[N:10][C:11]=2[CH:12]=1参加物
4
実験手順
To a solution of (Z)-2-(8,9-dimethoxy-2,3-dihydroimidazo[1,2-c]quinazolin-5-yl)-1-(3-pyridinyl)ethenol (16.8 mg, 0.05 mmol)) in dioxane (15 ml) at room temperature was added aqueous 6N HCl solution (0.05 ml). After being stirred for 30 minutes, the mixture was dried under reduced pressure to give (Z)-2-(8,9-dimethoxy-2,3-dihydroimidazo[1,2-c]quinazolin-5-yl)-1-(3-pyridinyl)ethenol hydrochloride (18.5 mg, quantitative) as a yellow solid.
後処理
- customthe mixture was dried under reduced pressure
出典と根拠
- ORDレコード
- ord-4c26e1bad9fc42829ff83b4561a516e3
- 出典データセット
- uspto-grants-2012_03
- 特許番号
- US08129386B2
関連ノート
読み込み中…